O’DONNELL, P. H., ARTZ, A. S., UNDEVIA, S. D., PAI, R. K., CERRO, P. D., HOROWITZ, S., . . . VAN BESIEN, K. (2010). Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: Reduced clearance at high doses and occurrence of late sinusoidal obstruction syndrome/veno-occlusive disease. Leuk Lymphoma.

O’DONNELL, PETER H., et al. "Phase I Study of Dose-escalated Busulfan With Fludarabine and Alemtuzumab As Conditioning for Allogeneic Hematopoietic Stem Cell Transplant: Reduced Clearance At High Doses and Occurrence of Late Sinusoidal Obstruction Syndrome/veno-occlusive Disease." Leuk Lymphoma 2010.

O’DONNELL, PETER H., et al. "Phase I Study of Dose-escalated Busulfan With Fludarabine and Alemtuzumab As Conditioning for Allogeneic Hematopoietic Stem Cell Transplant: Reduced Clearance At High Doses and Occurrence of Late Sinusoidal Obstruction Syndrome/veno-occlusive Disease." Leuk Lymphoma 2010.